4 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 4 mutual funds hold active equity positions in both Prism Johnson and Sanofi India. The scheme with the highest combined exposure is SBI Contra Fund (SBI MF), which holds a 0.48% stake in Prism Johnson and a 0.17% stake in Sanofi India, amounting to a combined conviction weight of 0.65%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Prism wt. | Sanofi wt. | Combined |
|---|---|---|---|
| SBI Contra FundSBI MF · Contra | 0.48% | 0.17% | |
| Nippon India Nifty Smallcap 250 Index FundNippon India MF · Index Fund | 0.13% | 0.47% | |
| SBI ELSS Tax Saver FundSBI MF · ELSS (Tax Saver) | 0.34% | 0.05% | |
| IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund | 0.01% | 0.02% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.